Global and Japan Retinal Biologics Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 08-Nov-2021
No. of pages: 95
Inquire Before Buying

Global Retinal Biologics Scope and Market Size

Retinal Biologics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Retinal Biologics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Macular Degeneration

- Diabetic Retinopathy

- Diabetic Macular Edema

- Uveitis

- Others

Segment by Application

- Hospitals

- Clinics

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Spark Therapeutics, Inc

- F. Hoffmann-La Roche Ltd

- Regeneron Pharmaceuticals, Inc

- AbbVie Inc

- Johnson & Johnson Services, Inc

- Amgen Inc

Global and Japan Retinal Biologics Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Retinal Biologics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Macular Degeneration
1.2.3 Diabetic Retinopathy
1.2.4 Diabetic Macular Edema
1.2.5 Uveitis
1.2.6 Others
1.3 Market by Application
1.3.1 Global Retinal Biologics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Retinal Biologics Market Perspective (2016-2027)
2.2 Retinal Biologics Growth Trends by Regions
2.2.1 Retinal Biologics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Retinal Biologics Historic Market Share by Regions (2016-2021)
2.2.3 Retinal Biologics Forecasted Market Size by Regions (2022-2027)
2.3 Retinal Biologics Industry Dynamic
2.3.1 Retinal Biologics Market Trends
2.3.2 Retinal Biologics Market Drivers
2.3.3 Retinal Biologics Market Challenges
2.3.4 Retinal Biologics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Retinal Biologics Players by Revenue
3.1.1 Global Top Retinal Biologics Players by Revenue (2016-2021)
3.1.2 Global Retinal Biologics Revenue Market Share by Players (2016-2021)
3.2 Global Retinal Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Retinal Biologics Revenue
3.4 Global Retinal Biologics Market Concentration Ratio
3.4.1 Global Retinal Biologics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Retinal Biologics Revenue in 2020
3.5 Retinal Biologics Key Players Head office and Area Served
3.6 Key Players Retinal Biologics Product Solution and Service
3.7 Date of Enter into Retinal Biologics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Retinal Biologics Breakdown Data by Type
4.1 Global Retinal Biologics Historic Market Size by Type (2016-2021)
4.2 Global Retinal Biologics Forecasted Market Size by Type (2022-2027)
5 Retinal Biologics Breakdown Data by Application
5.1 Global Retinal Biologics Historic Market Size by Application (2016-2021)
5.2 Global Retinal Biologics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Retinal Biologics Market Size (2016-2027)
6.2 North America Retinal Biologics Market Size by Type
6.2.1 North America Retinal Biologics Market Size by Type (2016-2021)
6.2.2 North America Retinal Biologics Market Size by Type (2022-2027)
6.2.3 North America Retinal Biologics Market Size by Type (2016-2027)
6.3 North America Retinal Biologics Market Size by Application
6.3.1 North America Retinal Biologics Market Size by Application (2016-2021)
6.3.2 North America Retinal Biologics Market Size by Application (2022-2027)
6.3.3 North America Retinal Biologics Market Size by Application (2016-2027)
6.4 North America Retinal Biologics Market Size by Country
6.4.1 North America Retinal Biologics Market Size by Country (2016-2021)
6.4.2 North America Retinal Biologics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Retinal Biologics Market Size (2016-2027)
7.2 Europe Retinal Biologics Market Size by Type
7.2.1 Europe Retinal Biologics Market Size by Type (2016-2021)
7.2.2 Europe Retinal Biologics Market Size by Type (2022-2027)
7.2.3 Europe Retinal Biologics Market Size by Type (2016-2027)
7.3 Europe Retinal Biologics Market Size by Application
7.3.1 Europe Retinal Biologics Market Size by Application (2016-2021)
7.3.2 Europe Retinal Biologics Market Size by Application (2022-2027)
7.3.3 Europe Retinal Biologics Market Size by Application (2016-2027)
7.4 Europe Retinal Biologics Market Size by Country
7.4.1 Europe Retinal Biologics Market Size by Country (2016-2021)
7.4.2 Europe Retinal Biologics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Retinal Biologics Market Size (2016-2027)
8.2 Asia-Pacific Retinal Biologics Market Size by Type
8.2.1 Asia-Pacific Retinal Biologics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Retinal Biologics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Retinal Biologics Market Size by Type (2016-2027)
8.3 Asia-Pacific Retinal Biologics Market Size by Application
8.3.1 Asia-Pacific Retinal Biologics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Retinal Biologics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Retinal Biologics Market Size by Application (2016-2027)
8.4 Asia-Pacific Retinal Biologics Market Size by Region
8.4.1 Asia-Pacific Retinal Biologics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Retinal Biologics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Retinal Biologics Market Size (2016-2027)
9.2 Latin America Retinal Biologics Market Size by Type
9.2.1 Latin America Retinal Biologics Market Size by Type (2016-2021)
9.2.2 Latin America Retinal Biologics Market Size by Type (2022-2027)
9.2.3 Latin America Retinal Biologics Market Size by Type (2016-2027)
9.3 Latin America Retinal Biologics Market Size by Application
9.3.1 Latin America Retinal Biologics Market Size by Application (2016-2021)
9.3.2 Latin America Retinal Biologics Market Size by Application (2022-2027)
9.3.3 Latin America Retinal Biologics Market Size by Application (2016-2027)
9.4 Latin America Retinal Biologics Market Size by Country
9.4.1 Latin America Retinal Biologics Market Size by Country (2016-2021)
9.4.2 Latin America Retinal Biologics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Retinal Biologics Market Size (2016-2027)
10.2 Middle East & Africa Retinal Biologics Market Size by Type
10.2.1 Middle East & Africa Retinal Biologics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Retinal Biologics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Retinal Biologics Market Size by Type (2016-2027)
10.3 Middle East & Africa Retinal Biologics Market Size by Application
10.3.1 Middle East & Africa Retinal Biologics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Retinal Biologics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Retinal Biologics Market Size by Application (2016-2027)
10.4 Middle East & Africa Retinal Biologics Market Size by Country
10.4.1 Middle East & Africa Retinal Biologics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Retinal Biologics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Spark Therapeutics, Inc
11.1.1 Spark Therapeutics, Inc Company Details
11.1.2 Spark Therapeutics, Inc Business Overview
11.1.3 Spark Therapeutics, Inc Retinal Biologics Introduction
11.1.4 Spark Therapeutics, Inc Revenue in Retinal Biologics Business (2016-2021)
11.1.5 Spark Therapeutics, Inc Recent Development
11.2 F. Hoffmann-La Roche Ltd
11.2.1 F. Hoffmann-La Roche Ltd Company Details
11.2.2 F. Hoffmann-La Roche Ltd Business Overview
11.2.3 F. Hoffmann-La Roche Ltd Retinal Biologics Introduction
11.2.4 F. Hoffmann-La Roche Ltd Revenue in Retinal Biologics Business (2016-2021)
11.2.5 F. Hoffmann-La Roche Ltd Recent Development
11.3 Regeneron Pharmaceuticals, Inc
11.3.1 Regeneron Pharmaceuticals, Inc Company Details
11.3.2 Regeneron Pharmaceuticals, Inc Business Overview
11.3.3 Regeneron Pharmaceuticals, Inc Retinal Biologics Introduction
11.3.4 Regeneron Pharmaceuticals, Inc Revenue in Retinal Biologics Business (2016-2021)
11.3.5 Regeneron Pharmaceuticals, Inc Recent Development
11.4 AbbVie Inc
11.4.1 AbbVie Inc Company Details
11.4.2 AbbVie Inc Business Overview
11.4.3 AbbVie Inc Retinal Biologics Introduction
11.4.4 AbbVie Inc Revenue in Retinal Biologics Business (2016-2021)
11.4.5 AbbVie Inc Recent Development
11.5 Johnson & Johnson Services, Inc
11.5.1 Johnson & Johnson Services, Inc Company Details
11.5.2 Johnson & Johnson Services, Inc Business Overview
11.5.3 Johnson & Johnson Services, Inc Retinal Biologics Introduction
11.5.4 Johnson & Johnson Services, Inc Revenue in Retinal Biologics Business (2016-2021)
11.5.5 Johnson & Johnson Services, Inc Recent Development
11.6 Amgen Inc
11.6.1 Amgen Inc Company Details
11.6.2 Amgen Inc Business Overview
11.6.3 Amgen Inc Retinal Biologics Introduction
11.6.4 Amgen Inc Revenue in Retinal Biologics Business (2016-2021)
11.6.5 Amgen Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Retinal Biologics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Macular Degeneration
Table 3. Key Players of Diabetic Retinopathy
Table 4. Key Players of Diabetic Macular Edema
Table 5. Key Players of Uveitis
Table 6. Key Players of Others
Table 7. Global Retinal Biologics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Retinal Biologics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Retinal Biologics Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Retinal Biologics Market Share by Regions (2016-2021)
Table 11. Global Retinal Biologics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Retinal Biologics Market Share by Regions (2022-2027)
Table 13. Retinal Biologics Market Trends
Table 14. Retinal Biologics Market Drivers
Table 15. Retinal Biologics Market Challenges
Table 16. Retinal Biologics Market Restraints
Table 17. Global Retinal Biologics Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Retinal Biologics Market Share by Players (2016-2021)
Table 19. Global Top Retinal Biologics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinal Biologics as of 2020)
Table 20. Ranking of Global Top Retinal Biologics Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Retinal Biologics Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Retinal Biologics Product Solution and Service
Table 24. Date of Enter into Retinal Biologics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Retinal Biologics Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Retinal Biologics Revenue Market Share by Type (2016-2021)
Table 28. Global Retinal Biologics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Retinal Biologics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Retinal Biologics Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Retinal Biologics Revenue Market Share by Application (2016-2021)
Table 32. Global Retinal Biologics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Retinal Biologics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Retinal Biologics Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Retinal Biologics Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Retinal Biologics Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Retinal Biologics Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Retinal Biologics Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Retinal Biologics Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Retinal Biologics Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Retinal Biologics Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Retinal Biologics Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Retinal Biologics Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Retinal Biologics Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Retinal Biologics Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Retinal Biologics Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Retinal Biologics Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Retinal Biologics Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Retinal Biologics Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Retinal Biologics Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Retinal Biologics Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Retinal Biologics Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Retinal Biologics Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Retinal Biologics Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Retinal Biologics Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Retinal Biologics Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Retinal Biologics Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Retinal Biologics Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Retinal Biologics Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Retinal Biologics Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Retinal Biologics Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Retinal Biologics Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Retinal Biologics Market Size by Country (2022-2027) & (US$ Million)
Table 64. Spark Therapeutics, Inc Company Details
Table 65. Spark Therapeutics, Inc Business Overview
Table 66. Spark Therapeutics, Inc Retinal Biologics Product
Table 67. Spark Therapeutics, Inc Revenue in Retinal Biologics Business (2016-2021) & (US$ Million)
Table 68. Spark Therapeutics, Inc Recent Development
Table 69. F. Hoffmann-La Roche Ltd Company Details
Table 70. F. Hoffmann-La Roche Ltd Business Overview
Table 71. F. Hoffmann-La Roche Ltd Retinal Biologics Product
Table 72. F. Hoffmann-La Roche Ltd Revenue in Retinal Biologics Business (2016-2021) & (US$ Million)
Table 73. F. Hoffmann-La Roche Ltd Recent Development
Table 74. Regeneron Pharmaceuticals, Inc Company Details
Table 75. Regeneron Pharmaceuticals, Inc Business Overview
Table 76. Regeneron Pharmaceuticals, Inc Retinal Biologics Product
Table 77. Regeneron Pharmaceuticals, Inc Revenue in Retinal Biologics Business (2016-2021) & (US$ Million)
Table 78. Regeneron Pharmaceuticals, Inc Recent Development
Table 79. AbbVie Inc Company Details
Table 80. AbbVie Inc Business Overview
Table 81. AbbVie Inc Retinal Biologics Product
Table 82. AbbVie Inc Revenue in Retinal Biologics Business (2016-2021) & (US$ Million)
Table 83. AbbVie Inc Recent Development
Table 84. Johnson & Johnson Services, Inc Company Details
Table 85. Johnson & Johnson Services, Inc Business Overview
Table 86. Johnson & Johnson Services, Inc Retinal Biologics Product
Table 87. Johnson & Johnson Services, Inc Revenue in Retinal Biologics Business (2016-2021) & (US$ Million)
Table 88. Johnson & Johnson Services, Inc Recent Development
Table 89. Amgen Inc Company Details
Table 90. Amgen Inc Business Overview
Table 91. Amgen Inc Retinal Biologics Product
Table 92. Amgen Inc Revenue in Retinal Biologics Business (2016-2021) & (US$ Million)
Table 93. Amgen Inc Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Retinal Biologics Market Share by Type: 2020 VS 2027
Figure 2. Macular Degeneration Features
Figure 3. Diabetic Retinopathy Features
Figure 4. Diabetic Macular Edema Features
Figure 5. Uveitis Features
Figure 6. Others Features
Figure 7. Global Retinal Biologics Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Retinal Biologics Report Years Considered
Figure 12. Global Retinal Biologics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Retinal Biologics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Retinal Biologics Market Share by Regions: 2020 VS 2027
Figure 15. Global Retinal Biologics Market Share by Regions (2022-2027)
Figure 16. Global Retinal Biologics Market Share by Players in 2020
Figure 17. Global Top Retinal Biologics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinal Biologics as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Retinal Biologics Revenue in 2020
Figure 19. Global Retinal Biologics Revenue Market Share by Type (2016-2021)
Figure 20. Global Retinal Biologics Revenue Market Share by Type (2022-2027)
Figure 21. North America Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Retinal Biologics Market Share by Type (2016-2027)
Figure 23. North America Retinal Biologics Market Share by Application (2016-2027)
Figure 24. North America Retinal Biologics Market Share by Country (2016-2027)
Figure 25. United States Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Retinal Biologics Market Share by Type (2016-2027)
Figure 29. Europe Retinal Biologics Market Share by Application (2016-2027)
Figure 30. Europe Retinal Biologics Market Share by Country (2016-2027)
Figure 31. Germany Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Retinal Biologics Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Retinal Biologics Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Retinal Biologics Market Share by Region (2016-2027)
Figure 41. China Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Retinal Biologics Market Share by Type (2016-2027)
Figure 49. Latin America Retinal Biologics Market Share by Application (2016-2027)
Figure 50. Latin America Retinal Biologics Market Share by Country (2016-2027)
Figure 51. Mexico Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Retinal Biologics Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Retinal Biologics Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Retinal Biologics Market Share by Country (2016-2027)
Figure 57. Turkey Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Retinal Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Spark Therapeutics, Inc Revenue Growth Rate in Retinal Biologics Business (2016-2021)
Figure 61. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Retinal Biologics Business (2016-2021)
Figure 62. Regeneron Pharmaceuticals, Inc Revenue Growth Rate in Retinal Biologics Business (2016-2021)
Figure 63. AbbVie Inc Revenue Growth Rate in Retinal Biologics Business (2016-2021)
Figure 64. Johnson & Johnson Services, Inc Revenue Growth Rate in Retinal Biologics Business (2016-2021)
Figure 65. Amgen Inc Revenue Growth Rate in Retinal Biologics Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs